| Welcome, Guest |
You have to register before you can post on our site.
|
| Forum Statistics |
» Members: 2,795
» Latest member: kidwinj
» Forum threads: 7,059
» Forum posts: 123,415
Full Statistics
|
| Latest Threads |
Odds and Ends ... With So...
Forum: The Lounge
Last Post: IceWizard
11-13-2026, 01:20 AM
» Replies: 11
» Views: 3,032
|
Here are a couple I found
Forum: IOPList Suggested IOP's
Last Post: gujjernoran
11-12-2026, 08:26 PM
» Replies: 1
» Views: 759
|
www.MacroMass.COM.PH
Forum: IOPList (Approved & Recommended)
Last Post: Macro Mass
11-11-2026, 04:56 PM
» Replies: 3,854
» Views: 7,122,882
|
The Juke Box is OPEN
Forum: The Lounge
Last Post: Mr. HIND
11-09-2026, 08:03 AM
» Replies: 2,939
» Views: 1,650,989
|
MOVIES
Forum: The Lounge
Last Post: IceWizard
11-09-2026, 05:10 AM
» Replies: 147
» Views: 48,488
|
www.MacroMass.COM.PH
Forum: IOP Discounts, Offers & More
Last Post: Macro Mass
11-08-2026, 09:07 PM
» Replies: 143
» Views: 79,729
|
Humorous Smilies
Forum: The Lounge
Last Post: IceWizard
11-02-2026, 01:22 AM
» Replies: 4,936
» Views: 4,246,361
|
Deaths So Far (and it's j...
Forum: World News
Last Post: IceWizard
10-31-2026, 07:15 PM
» Replies: 51
» Views: 14,381
|
'Biscuit' the dog is late...
Forum: World News
Last Post: IceWizard
10-31-2026, 06:16 PM
» Replies: 0
» Views: 136
|
GAME - Change one word ga...
Forum: The Lounge
Last Post: IceWizard
10-15-2026, 05:21 AM
» Replies: 2,142
» Views: 1,012,383
|
|
|
| Thank you |
|
Posted by: Lunar - 09-29-2018, 05:33 AM - Forum: Suggestions & Technical
- Replies (5)
|
 |
Charon, thank you for every second...... I appreciate each one. Love, Light joy
If only I had ypur resolve
I would savor alll moments
this community is here fore a reason. RISK REDUCTION.
Ask, LISTEN, and be patient.
I thought I was smart a couple months back but got ripped the f* off. Lack of patience was my down fall
If you came across the this forum, consider yourself one of the lucky few. But, I stress, de nuevo, patience is a virtue. Ask your questions, this forum is here to help
|
|
|
| Newest Members Please Note |
|
Posted by: Charon - 09-27-2018, 01:27 AM - Forum: Welcome
- Replies (6)
|
 |
Please Note: We recently received word of an update on our forum that has affected a number of accounts. We apologize for the problem. Some of you will have to apply yet again.
It would appear fewer than twenty posters were affected.
|
|
|
| Scammers on ttm thread right now |
|
Posted by: Charon - 09-25-2018, 10:49 PM - Forum: Blacklist
- Replies (24)
|
 |
Watch out for this one. Hitting up people on another forum.
bryceman41 wrote
ramandjam420@tutamail.com
He was banned by me years ago as a SCAM. Please don't fall for it.
|
|
|
Experienced Panic Attacks? What do you do? |
|
Posted by: quickfix - 09-25-2018, 02:45 AM - Forum: Anxiety Depression & Stress
- Replies (43)
|
 |
Hello guys, I wanted to create a thread where you could share your experience of the worst ever panic attack in your life and how you managed to deal with it.
I know there not going to kill us, and we always remind our selves it's there to keep us alive from danger and it will pass. But when one suddenly comes on especially a very bad one sometimes you forget all those things. I've suffered from panic attacks all my life, if I look back from now they have become worse but I've been able to manage them better when I am having one.
However there was one a couple months ago where I thought I literally lost my mind, I only realized that it was panic attack a couple hours after.
I was in the middle of cold turkey from diaz, and was going out for dinner with a friend. Now to anyone else this seems like a fabulous time. Not for me. As soon as he arrived I started to shake, and was acting very awkward then could not pronounce words properly and started to get emotional for no bloody reason. He said are you okay? I said I need to dash to the bathroom I'll be right back. Luckily I had propranolol on hand as my palpitations where obvious from me gasping for air, the room started to spin it almost felt like a bad trip it took about 30min for me to relax a little. I lied to my friend saying it was an allergic reaction as I didn't want him to know I was ct from a benzo or that I used to take them. He then said I think your having a panic attack, and relax. I could see he was trying to comfort me, but asking every 10min are you okay was not helping.
I cut the dinner short, and took an uber back (that was another horrible experience nearly threw up) my friend insisted to comeback with me so I agreed.
Once we got to mine, I asked if he could give me an hour. So I could lay my head down for a bit as my heart rate was
160bpm and blood pressure 170/100 this was two hours in. About 90min later my numbers settled and I felt a little better.
probably due to the beta blocker, the mental effects where still there. I think in total this was a 4 hour panic attack.
Has anyone else experienced anything like it, and how did you deal with it?
Thanks QF
|
|
|
| Trump takes on big pharma |
|
Posted by: IceWizard - 09-24-2018, 02:27 PM - Forum: World News
- No Replies
|
 |
Published in PharmaTimes magazine - September 2018
The president's FDA commissioner could become a “Scrooge” for the industry
In the June 2017 issue of PharmaTimes, we wrote about president’s Trump nomination of Dr Scott Gottlieb as the next FDA commissioner. A physician who had deep links with Big Pharma, Dr Gottlieb was viewed by critics as being too biased to assume the role as the nation’s top drug regulator. However, he also felt that “the agency should demonstrate more flexibility in granting product licences” and “called for the faster approval of complex generics in order to compete with the higher-priced originals”; policies which echo Trump’s campaign rhetoric to bring down perceived high drug prices.
Since his appointment as the 23rd FDA commissioner in May 2017, has Dr Gottlieb fulfilled the above promises and will these be a threat to big pharma’s current modus operandi?
“They’re getting away with murder”
While Trump has never been the type to stay focused on any topic, a few issues have attracted his constant attention, including the Iranian nuclear deal, the US-China trade war and Big Pharma drug pricing. He has consistently referred to the industry as “getting away with murder”, accusing them of engaging in price gouging and anticompetitive practices.
In July this year, Pfizer reversed or postponed its drug hikes a day after Trump’s Twitter criticism that the company, amongst others, "should be ashamed for raising drug prices for no reason; taking advantage of the poor and others unable to defend themselves, while at the same time giving bargain-basement prices to other countries in Europe & elsewhere". However, it is not necessarily Trump that Big Pharma should be worried about but his FDA commissioner. While Trump pays very little attention to policy implementation, Dr Gottlieb has been laser-focused on cutting drug prices in the past year.
One of Dr Gottlieb’s biggest focus has been on increasing market access and the ease at which generic drugmakers can manufacture, import and sell drugs. A major stumbling block to achieving this is the significant and perceived obstructive tactics of Big Pharma.
Although some critics see Dr Gottlieb’s price-cutting proposals as inappropriate government interference, he sees no such contradiction. While he believes that free market forces and vibrant competitions are vital for lowering drug prices and increasing accessibility, he feels that it is vital that the FDA is able to reform the regulatory system, including speeding up approvals for generic alternatives, thus allowing competition to emerge in the first place.
A major accusation is that Big Pharma erects barriers to entry by preventing sales of their original drugs to generic drug-makers who need to buy between 2,000-5,000 doses to conduct bioequivalence studies. In the very first month of Dr Gottlieb’s appointment, the FDA set up a website to effectively name and shame companies who have failed to provide samples for bioequivalence testing. Fifty branded drugs appeared on the list initially, including well-known drugs like Roche’s Accutane (acne), Actelion’s Tracleer (PAH) and AZ’s Brilinta (anti-platelets). Manufacturers of original drugs were accused of using on-going risk mitigation plans as an excuse for not supplying the samples, or simply instructing their distributors not to sell their drugs to potential generics competitors.
While Big Pharma is a main target, Dr Gottlieb has also criticised pharmacy benefit managers (PBMs) and the control that the top three firms, which together account for over two-thirds of the market, has led to a lack of competition. Citing their role as middleman, he stated that PBMs are equally as responsible as big pharma for limiting choices and keeping drug prices high. PBMs often ignore cheaper generics and biosimilars as they don’t receive rebates that they would otherwise have collected from manufacturers of original medicines. As a result, despite the presence of cheaper options, patients are forced to purchase expensive medicines due to the above practice.
What has he achieved so far?
The FDA has been speeding up its drug approval process with 46 new drugs being approved in 2017, including therapies for cancers and uncommon diseases like Celgene’s Idhifa (leukaemia), Roche’s Ocrevus (multiple sclerosis) and Teva’s Austedo (Huntington’s). However, as many of these new treatments have similar mechanism of actions as those already on the market, it has generated concerns whether the new drugs are truly groundbreaking. With critics citing a study showing that between 2002 and 2014, newly-approved cancer drugs only prolonged life by a few short months, they have concerns that this will only worsen with more mediocre cancer drugs making their way into the market under Dr Gottlieb’s stewardship.
In response, Dr Gottlieb noted that in some patients, their lives have been prolonged for a much longer period than the studies indicated. Needless to say, for patients with cancer, even a few more months of life can be very significant for them and their families. Additionally, further research can be conducted to ascertain why these patients are able to survive longer than expected, thus leading to improvements in later versions of these drugs
In an effort to increase the availability of biosimilars, Dr Gottlieb has recently floated a highly controversial idea - circumventing the need to conduct expensive and time-consuming 'bridging’ studies. Under a proposed arrangement, the FDA will allow generics companies to import less expensive biosimilars from the EU without the need to carry out studies to prove that the European biologics are similar to the American versions. He rightly pointed out that in many cases, both versions are manufactured in the same plants anyway. If the plans do proceed, it will address the fact that the US currently lags the EU in terms of approved biosimilars and their usage. Of course, there are many legal challenges and he has instructed the agency’s lawyers to look into viable solutions. Another consideration is whether the biosimilar manufacturers would want to go along and cannibalise the lucrative US markets with supplies designated for the EU; they may want to seek outright US product approvals for their own long-term gains.
Of course, it is still early days, and there is a long way to go to make drugs more affordable in the US. However, as Dr Gottlieb noted, none of his proposals will be a “silver bullet” on their own and will not provide instant answers for patients. But with radical changes, these individual policies will combine to create a more efficient system of drug approval and fairer accessibility to medicines, thus benefiting patients and the industry alike in the long run.
James Huang is a policy researcher and Stephen Huang is a pharmaceutical medicine consultant, both at SCP Medical
|
|
|
| Trump wants a new war on drugs |
|
Posted by: IceWizard - 09-24-2018, 02:18 PM - Forum: World News
- Replies (2)
|
 |
Old news.... but relevant
By THE TIMES EDITORIAL BOARD
MAR 20, 2018
![[Image: QW7NNQF6N5GCTOCJUEBTKHVSE4.jpg]](https://www.latimes.com/resizer/BEwhx6pXg10G6_HPmgsEJWMDvaQ=/1400x0/arc-anglerfish-arc2-prod-tronc.s3.amazonaws.com/public/QW7NNQF6N5GCTOCJUEBTKHVSE4.jpg)
President Trump speaks March 19 in Manchester, N.H., about his plan to combat opioid drug addiction. (Elise Amendola / Associated Press)
President Trump's opioid response plan might have multiple prongs, but when he unveiled it Monday, he clearly was most interested in the prong that gets "very tough" on drug dealers. We know this because he said so approximately 5,000 times during a speech announcing the new plan in New Hampshire, a state chosen as the backdrop because it is one of those hardest hit by opioid addiction and overdose deaths.
A few examples: "If we don't get tough on the drug dealers, we are wasting our time." "Toughness is the thing they most fear." "We have got to get tough. This isn't about nice anymore." What "tough" means to Trump, it turns out, is not attacking addiction with treatment. It means throwing more low-level drug dealers in jail, building a wall along the southern border and cutting funding for sanctuary cities in California that he (wrongly) says protect drug dealers. Also, it means executing drug dealers, because that works so well in other countries. (Not.)
Sorry to be glib, but we have a hard time taking Trump seriously when his long-awaited response to the deadly opioid crisis that killed about 64,000 Americans in 2016 and probably even more in 2017 relies on immigrant scapegoating, barbaric penalties and magical thinking. It's not even original. Trump's get-tough approach is little more than a reboot of the failed "War on Drugs" from the 1980s, in which the federal government spent enormous sums trying — and failing — to stop the crack cocaine crisis by throwing people in prison, a disproportionate amount of whom were African American and Latino.
Quote:Trump’s get-tough approach is little more than a reboot of the failed 'War on Drugs' from the 1980s.
[size=undefined]
Even more worrisome than the recycled drug war posturing (Trump is also touting a Just Say No-style advertising campaign to tell kids how bad drugs are) was his praise for countries with zero-tolerance drug policies. He didn't say which countries, but clearly he was referring to the Philippines, where President Rodrigo Duterte's drug crackdown has resulted in the extrajudicial killing of thousands of people (children included) for petty crimes or drug use, according to Human Rights Watch.
Perhaps we shouldn't be surprised that the president is, once again, embracing policy notions from the 20th century. But before Monday, there was reason to believe that he viewed opioid addiction properly as a public health crisis, not a reason to launch War on Drugs II. His first speech on the topic in October, while vague, promised action on this "public health emergency." A few days later the commission he convened to study the problem and come up with evidence-based solutions released a 131-page report with 56 recommendations, none of which suggested killing people. The commission did call for enhanced law enforcement and stiffer penalties, but as part of a comprehensive strategy that included such sensible actions as tracking opioid prescriptions, improving drug take-back efforts (unused prescription opioids often get filched and sold on the black market) and providing better access to quality substance abuse treatment.
There was some good stuff in Trump's announcement, such as holding pharmaceutical companies responsible for their role in pushing out opioids, making legal drugs used in addiction treatment cheaper, developing non-addictive painkillers, making sure that first responders and schools have access to the overdose-prevention drug Naloxone, and working to reduce overprescription of opioids. But even if those prongs hadn't been overshadowed by all the talk of being tough and executing kingpins, they still wouldn't be enough. Not when Trump's own budget proposal would gut Medicaid,which is a crucial source of substance abuse treatment in states like New Hampshire. And not when there is so much more that could be done to keep addicts alive until they get treatment.
If there's just one lesson to be learned from the country's last attempt to grapple with a drug crisis, it is that we can't arrest our way out of drug addiction. Or kill our way out of it.
Just say no to Trump's opioid plan.
[/size]
|
|
|
| The NY Debt Clock countdown to next... |
|
Posted by: Charon - 09-23-2018, 10:24 PM - Forum: World News
- Replies (4)
|
 |
BUSINESS
Next crash will be ‘worse than the Great Depression’: experts
By John Aidan Byrne September 22, 2018 | 8:29pm
The National Debt Clock in New York City.
U.S. DEBT
US student debt might lead to the next financial crisis
China has the ultimate weapon in trade war with US
How GOP tax cuts may hurt the US down the line
Russia sold most of its US government securities around Helsinki summit
Ten years ago, it was too-easy credit that brought financial markets to their knees. Today, it could be a global debt of $247 trillion that causes the next crash.
After a decade of escalating US household debt brought on by low wages and the national debt more than doubling over the same time frame, to $21 trillion, debt could soon put the brakes on this economic recovery, analysts warn.
“We think the major economies are on the cusp of this turning into the worst recession we have seen in 10 years,” said Murray Gunn, head of global research at Elliott Wave International.
And in a note, he added: “Should the [US] economy start to shrink, and our analysis suggests that it will, the high nominal levels of debt will instantly become a very big issue.”
The economic stats:
US household debt of $13.3 trillion now exceeds the 2008 peak. That’s due in part to mortgage lending, which is hovering near its decade-ago level of $9 trillion-plus.
Student loans outstanding have skyrocketed from $611 billion in 2008 to around $1.5 trillion today.
Auto loans, at nearly $1.25 trillion, have exceeded the 2008 total, while credit card balances are just as high now as before the Great Recession.
Meanwhile, global debt — a result of central bankers flooding economies with cheap money to lift them out of an funk — is now $247 trillion, up from $177 trillion in 2008. That is close to 2 ¹/₂ times the size of the global economy.
“We won’t be able to call it a recession, it’s going to be worse than the Great Depression,” said economic commentator Peter Schiff, forecasting a major economic downturn as early as the tail end of the Trump presidency’s first term. “The US economy is in so much worse shape than it was a decade ago.”
Economic theorists say insurmountable debt is the big kahuna. The huge sums today certainly fed the boom times. But since it must eventually be repaid, the tipping point will come when a wave of defaults by overwhelmed borrowers — potentially squeezed by rising interest rates — leads to a widespread reduction in spending and incomes, economists explain.
Although Schiff has gotten some calls wrong in the past — he incorrectly predicted the US Federal Reserve would fail in its roundabout quantitative easing campaign to “reflate” housing and stocks in the wake of the financial crisis — he is convinced he is right on the money this time.
“I think we are going to have a dollar crisis — you think the Turkish lira looks bad now, wait till you see when the dollar is imploding and we have a sovereign debt crisis in the US,” he told The Post. “The US government is going to be given a choice between defaulting on the debt, or else massive runaway inflation.”
Earlier this year, Goldman Sachs said the fiscal outlook for the US was “not good,” and could threaten the nation’s economic security during the next recession.
Schiff dismisses the latest batch of positive indicators, including the lowest unemployment rate in a generation, soaring business confidence spurred by President Trump’s tax cuts and the Dow hitting record highs. “Obviously, there is a whole lot of optimism — but there is a very good chance the US economy is in recession within the next two years. This is already the second-longest economic expansion in history,” Schiff said, adding that recent dips in new housing starts and auto sales may be red flags.
Gunn sees a brutal deflationary spiral ahead in the next downturn.
“People will look to central banks to help them out, but the authorities will be found wanting,” Gunn warned.
“Our prediction is that central banks will go from being feted for ‘saving the world’ in 2008 to being vilified for being impotent in the coming deflationary crash.”
FILED UNDER DEBT , GREAT DEPRESSION , INTEREST RATES , RECESSION , U.S. DEBT
Warren Buffett’s Berkshire Hathaway Keeps Hitting New Highs—and It...
COLUMNISTS
|
|
|
|